Expression of bone morphogenetic proteins in fracture healing.

Fracture healing involves a complex interaction of many local and systemic regulatory factors. Recently, the presence of several bone morphogenetic proteins and their receptors in the fracture healing process has been described. During the early stages of fracture healing, only a minimum number of primitive cells are expressing bone morphogenetic proteins in the fracture callus. As the process of endochondral ossification proceeds, the presence of bone morphogenetic proteins and their receptors increases dramatically, especially in the primitive mesenchymal and chondrocytic cells. While the cartilaginous component of the callus matures with a concomitant decrease in the number of primitive cells, there is a concomitant decrease in presence of bone morphogenetic protein expressing cells. As osteoblasts start to lay down woven bone on the chondroid matrix, these osteoblastic cells express bone morphogenetic proteins and their receptors. The presence of bone morphogenetic proteins decreases, however, as lamellar bone replaces the primitive woven bone. A similar observation is seen in the areas of the callus undergoing intramembranous ossification. Initially, within several days after the fracture, periosteal cells and osteoblasts show intense expression of bone morphogenetic proteins and their receptors. As the woven bone is replaced with mature lamellar bone, the expression of bone morphogenetic protein decreases. These data and the knowledge of bone morphogenetic proteins' strong osteoinductive capacities suggest that individual bone morphogenetic proteins play important yet different roles during fracture repair.

[1]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[2]  M. Bolander,et al.  Role of Transforming Growth Factor‐β in Fracture Repair , 1990 .

[3]  K. Miyazono,et al.  Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  M. Sporn,et al.  Transforming Growth Factor , 1990 .

[5]  T. Einhorn,et al.  Production of a standard closed fracture in laboratory animal bone , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[6]  Y. Jin,et al.  Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions. , 1990, Clinical orthopaedics and related research.

[7]  E. Wang,et al.  Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. , 1991, Archives of otolaryngology--head & neck surgery.

[8]  M. Sporn,et al.  Transforming growth factor-beta. Multiple actions and potential clinical applications. , 1989, JAMA.

[9]  A. Weiland,et al.  Immunolocalization and expression of bone morphogenetic proteins 2 and 4 in fracture healing , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  J. Triffitt Initiation and enhancement of bone formation. A review. , 1987, Acta orthopaedica Scandinavica.

[11]  V. Rosen,et al.  The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. , 1992, The Journal of bone and joint surgery. American volume.

[12]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[13]  Clifford J. Tabin,et al.  Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.

[14]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  Y. Hoshino,et al.  Immunohistochemical Demonstration of Bone Morphogenetic Protein‐2 and Transforming Growth Factor‐β in the Ossification of the Posterior Longitudinal Ligament of the Cervical Spine , 1992, Spine.

[16]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Takaoka,et al.  Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  M. Bolander,et al.  Transforming growth factor-beta in the regulation of fracture repair. , 1990, The Orthopedic clinics of North America.

[19]  M. Bolander,et al.  Role of transforming growth factor-beta in fracture repair. , 1990, Annals of the New York Academy of Sciences.

[20]  O. Oni Fracture healing perspectives. , 1987, Clinical orthopaedics and related research.

[21]  E. Canalis,et al.  Growth factors and the regulation of bone remodeling. , 1988, The Journal of clinical investigation.

[22]  Y. Jin,et al.  The relationship between bone morphogenetic protein and neoplastic bone diseases. , 1990, Clinical orthopaedics and related research.

[23]  M. Bolander,et al.  Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.